Add BrightSurf on Google Email

University of Birmingham


Adding cell-based vaccine to liver cancer therapy slows cancer progression in patients with liver cancer

A new study found that a cell-based vaccine using dendritic cells can improve progression-free survival time for patients with intermediate-stage primary liver cancer. The ImmunoTACE trial showed an average of 18 months of tumor progression compared to 10 months in the control group.

SourceUniversity of Birmingham·JournalClinical Cancer Research·TypeRandomized controlled/clinical trial·DateAug 26, 2025

Probiotics for preterm babies lowered antibiotic resistant bacteria in gut, new study shows

A new study found that probiotics significantly reduced the presence of antibiotic-resistant bacteria and multidrug-resistant bacteria in the infant gut, while also promoting a more typical gut microbiome. This breakthrough has major implications for the global AMR crisis, particularly for preterm infants.

SourceUniversity of Birmingham·JournalNature Communications·TypeExperimental study·DateAug 15, 2025

Rise in expectant mothers in UK with autoimmune diseases since millennium

A recent study published in Lancet Rheumatology found a significant increase in autoimmune conditions among pregnant women in the UK since the millennium. The research analyzed electronic healthcare records from 2000-2021 and discovered a 4.7% rise in expectant mothers beginning pregnancy with autoimmune diseases, including psoriasis, ...

SourceUniversity of Birmingham·JournalThe Lancet Rheumatology·TypeData/statistical analysis·DateJun 2, 2025

Household action can play major role in climate change fight - study

A new study found that adopting low-carbon lifestyles can reduce global carbon footprints by 10.4 gigatons of CO2 equivalent, equivalent to 40.1% of household consumption-based emissions in 116 countries analysed. Researchers identified 21 low-carbon actions that could achieve this reduction if adopted by the top 23.7% of global emitters.

SourceUniversity of Birmingham·JournalNature Communications·TypeObservational study·DateMay 20, 2025

Blood cancer patients taking Bruton Tyrosine Kinase inhibitors should continue treatment at the time of COVID-19 vaccination, study shows

A new study suggests that blood cancer patients receiving Bruton Tyrosine Kinase inhibitors should continue their therapy while getting vaccinated against COVID-19. The IMPROVE trial found no improvement in antibody responses when BTKi therapy was paused for three weeks around the time of vaccination.

SourceUniversity of Birmingham·JournalThe Lancet Haematology·TypeRandomized controlled/clinical trial·DateApr 1, 2025

Smartwatches may help control diabetes through exercise

A new study found that smartwatches paired with a health app can encourage people with newly diagnosed Type 2 Diabetes to start and maintain purposeful exercise, leading to improvements in blood sugar levels and systolic blood pressure. The programme also helped participants lower cholesterol and improve their quality of life.

SourceUniversity of Birmingham·JournalBMJ Open·TypeObservational study·DateMar 26, 2025